Noida-based healthcare manufacturer Anondita Medicare Ltd. is set to open its ₹69.5 crore IPO on August 22, 2025. With a price band of ₹137–145 per share, the offering comprises a fresh issue of 47.93 lakh equity shares.
Anondita Medicare Ltd., headquartered in Noida, Uttar Pradesh, is a well-established player in the healthcare and contraceptive products industry. Incorporated with a focus on sexual wellness, the company manufactures male condoms under its flagship brand “Cobra.” With an installed capacity of 56.2 crore condoms annually across 11 manufacturing lines, Anondita has built a strong presence in the Indian contraceptive market.
The company will enter the capital markets with its Initial Public Offering (IPO) opening on August 22, 2025, for public subscription. The issue will remain open until August 26, 2025, following an anchor book launch on August 21 for institutional investors.
The IPO comprises a solely fresh issue of 47.93 lakh shares, with no offer-for-sale component. At the upper end of the ₹137–145 per share price band, Anondita Medicare is expected to raise around ₹69.5 crore.
As per the proposed utilization plan, ₹6 crore from the IPO proceeds will go toward the purchase of equipment and machinery, ₹35 crore will be allocated to meet working capital requirements, while the remaining funds will be set aside for potential acquisitions and general corporate purposes.
Investors should note that share allotment will be finalized by August 28, 2025, and equity shares of Anondita Medicare are scheduled to be listed on the NSE Emerge platform from September 1, 2025.
The IPO is being managed by Narnolia Financial Services Ltd., acting as the sole merchant banker for the issue.
This public issue marks a significant step for Anondita Medicare as it looks to strengthen its financial base, expand its operations, and enhance its competitiveness in the contraceptive and healthcare product space.
READ MORE ON
